Search

Sunanda Ranadive Phones & Addresses

  • Somerset, NJ
  • Franklin, NJ
  • 235 82Nd St, New York, NY 10028
  • 24 Agate Rd, East Brunswick, NJ 08816 (732) 249-3864
  • Great Neck, NY
  • Palisade, NJ
  • 2203 Enclave Cir, Somerset, NJ 08873 (732) 214-8700

Work

Position: Precision Production Occupations

Publications

Us Patents

Gatifloxacin Pentahydrate

View page
US Patent:
6413969, Jul 2, 2002
Filed:
Aug 17, 2001
Appl. No.:
09/932045
Inventors:
Krishnaswamy S. Raghavan - Cranbury NJ
Sunanda A. Ranadive - East Brunswick NJ
Jack Z. Gougoutas - Princeton NJ
John D. DiMarco - East Brunswick NJ
William L. Parker - Pennington NJ
Martha Davidovich - East Brunswick NJ
Ann Newman - Lafayette IN
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31496
US Classification:
51425308, 544363
Abstract:
There are provided in accordance with the present invention crystalline gatifloxacin pentahydrate represented by the formula in a highly homogeneous form with respect to other crystalline forms thereof.

Pediatric Formulation Of Gatifloxacin

View page
US Patent:
6589955, Jul 8, 2003
Filed:
May 9, 2002
Appl. No.:
10/143487
Inventors:
Krishnaswamy S. Raghavan - Cranbury NJ
Sunanda A. Ranadive - East Brunswick NJ
Kenneth S. Bembenek - Dayton NJ
Loutfy Benkerrour - Paris,
Veronique Trognon - La Turballe,
Richard G. Corrao - Jackson NJ
Luigi Esposito - Howell NJ
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31496
US Classification:
51425308, 544363
Abstract:
There is provided in accordance with the present invention the quinolone antibacterial gatifloxacin adequately taste-masked so that it can be utilized for pediatric formulations. A crystalline co-precipitate of gatifloxacin and one or both of stearic acid and palmitic acid in a narrow weight ratio has been found to effectively mask the bitter taste of gatifloxacin. The taste of gatifloxacin is effectively masked in the mouth and in aqueous suspension through a full dosage cycle, typically fourteen days. Gatifloxacin in the subject crystalline co-precipitates has been found to be readily available for absorption from the stomach.

Colonic Drug Delivery System

View page
US Patent:
5536507, Jul 16, 1996
Filed:
Jun 24, 1994
Appl. No.:
8/265167
Inventors:
Robert Abramowitz - Cranbury NJ
Sunanda A. Ranadive - East Brunswick NJ
Sailesh A. Varia - Plainsboro NJ
Nemichand B. Jain - Cranbury NJ
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 932
A61K 936
A61K 958
A61K 962
US Classification:
424479
Abstract:
A three component pharmaceutical formulation of one or more pharmacologically active substances such that greater than 80% of the pharmacologically active substance will be released in the large intestine. The first component comprises the pharmacologically active substance, microcrystalline cellulose, a pH-sensitive polymer, and optionally an osmotic agent. The second component is a delayed release coating, and the third component is an enteric coating.
Sunanda A Ranadive from Somerset, NJ, age ~76 Get Report